News Release

Postpartum breast cancer and survival in women with germline BRCA pathogenic variants

JAMA Network Open

Peer-Reviewed Publication

JAMA Network

About The Study: This study including 903 women with BRCA germline pathogenic variants found that a breast cancer diagnosis less than 10 years postpartum was associated with higher risk of mortality compared with nulliparous women and women diagnosed at least 10 years postpartum. These results should inform genetic counseling, prevention, and treatment strategies for BRCA pathogenic variant carriers. 

Authors: Zhenzhen Zhang, Ph.D., of Oregon Health & Science University in Portland, is the corresponding author. 

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ 

(doi:10.1001/jamanetworkopen.2024.7421)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.7421?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=041924

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.